Family Capital Trust Co Trims Stake in Danaher Co. (NYSE:DHR)

Family Capital Trust Co reduced its position in shares of Danaher Co. (NYSE:DHR) by 1.2% during the 4th quarter, HoldingsChannel reports. The firm owned 21,391 shares of the conglomerate’s stock after selling 258 shares during the period. Danaher comprises about 1.7% of Family Capital Trust Co’s investment portfolio, making the stock its 18th largest holding. Family Capital Trust Co’s holdings in Danaher were worth $4,910,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the 4th quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the 4th quarter valued at $31,000. Finally, Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher in the 3rd quarter worth $39,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on DHR shares. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Barclays lowered their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Finally, Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Down 1.5 %

Shares of DHR opened at $206.92 on Friday. Danaher Co. has a 52 week low of $205.79 and a 52 week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $149.45 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 2.68 and a beta of 0.83. The stock’s 50-day moving average price is $232.72 and its 200-day moving average price is $251.79.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business earned $2.09 EPS. On average, sell-side analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s payout ratio is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.